Fidelity Investments’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58 Buy
+3
New +$51 ﹤0.01% 5430
2026
Q1
Sell
-29
Closed -$426 5515
2025
Q4
$426 Buy
+29
New +$464 ﹤0.01% 5168
2025
Q1
Hold
0
-$5 5550
2024
Q4
Hold
0
5484
2024
Q3
Hold
0
-$15 5656
2024
Q2
Hold
0
5242

Other funds holding MRNY

Fidelity Investments's MRNY Position: Q2 2026 in Review

Fidelity Investments opened a new position in YieldMax MRNA Option Income Strategy ETF (MRNY) in Q2 2026: 3 shares worth $58. The stake represents ﹤0.01% of the portfolio and ranks #5430 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in MRNY as recently as Q4 2025.

Fidelity Investments first reported a position in MRNY in Q4 2025 and has held it in 2 quarters since. The position peaked at $426 in Q4 2025. 10 funds tracked by Wall St. Rank hold MRNY as of Q2 2026.

  • Fidelity Investments held 3 shares of YieldMax MRNA Option Income Strategy ETF worth $58 as of Q2 2026.
  • YieldMax MRNA Option Income Strategy ETF was a new Fidelity Investments position in Q2 2026.
  • YieldMax MRNA Option Income Strategy ETF made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5430 holding.
  • Fidelity Investments first reported a position in YieldMax MRNA Option Income Strategy ETF in Q4 2025 and has held it in 2 quarters since.
  • Fidelity Investments's YieldMax MRNA Option Income Strategy ETF position peaked at $426 in Q4 2025.
  • 10 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.